The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Constellation Pharmceticls I | COM | 210373106 | 121,757 | 6,009,702 | SH | OTR | 3,4,5,6,7,8,9,10 | 0 | 6,009,702 | 0 | |
Constellation Pharmceticls I | COM | 210373106 | 844 | 41,674 | SH | OTR | 3,8 | 0 | 41,674 | 0 | |
Gritstone Oncology Inc | COM | 39868T105 | 2,304 | 869,493 | SH | OTR | 1,2,3 | 0 | 869,493 | 0 | |
NGM Biopharmaceuticals Inc | COM | 62921N105 | 256,006 | 16,090,907 | SH | OTR | 1,2,3,4,5,6,7,8,9,10 | 0 | 16,090,907 | 0 | |
NGM Biopharmaceuticals Inc | COM | 62921N105 | 30,659 | 1,927,025 | SH | OTR | 3,8 | 0 | 1,927,025 | 0 | |
Nurix Therapeutics Inc | COM | 67080M103 | 235,848 | 6,755,881 | SH | OTR | 1,2,3,4,5,6,7,8,9,10 | 0 | 6,755,881 | 0 | |
ORIC Pharmaceuticals Inc. | COM | 68622P109 | 119,252 | 4,768,181 | SH | OTR | 1,2,3 | 0 | 4,768,181 | 0 | |
RAPT Therapeutics Inc | COM | 75382E109 | 179,692 | 5,580,497 | SH | OTR | 1,2,3,6,7,8,9,10 | 0 | 5,580,497 | 0 | |
RAPT Therapeutics Inc | COM | 75382E109 | 1,610 | 50,000 | SH | OTR | 3 | 0 | 50,000 | 0 | |
Revolution Medicines Inc | COM | 76155X100 | 47,677 | 1,370,022 | SH | OTR | 3,6,7,8,9,10 | 0 | 1,370,022 | 0 | |
Revolution Medicines Inc | COM | 76155X100 | 229,936 | 6,607,362 | SH | OTR | 3,8 | 0 | 6,607,362 | 0 |